REFERENCES
- T. M. Allen, C. Hansen, and F. Martin. (1991). Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half lives in vivo. Biochim. Biophys. Acta 1066:29–36.
- S. Amamath, and S. Umas. (1997). Liposomes in drug delivery: Progress and limitations. Int. J. Pharm. 154:123–140.
- I. A. Bakker-Woudenberg, A. F. Lokerse, and F. H. Roerdink. (1989). Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition. J. Pharmacol. Exp. Ther. 251 (1):321–327.
- M. Cocera, O. Lopez, L. Coderch, J. L. Parra, and A. de la Maza. (2003). Permeability investigations of phospholipid liposomes by adding cholesterol. Coll. Surf. A: Physicochem. Eng. Aspects 221:9–17.
- C. Dong, and J. A. Rogers. (1991). Polymer-coated liposomes: Stability coated and release liposomes of ASA from carboxymethyl chitin-coated liposomes. J. Control. Release 17:217–224.
- M. L. Elferink, J. G. Wit, and G. Veld. (1992). The stability and functional properties of proteoliposomes mixed with dextran derivatives bearing hydrophobic anchor groups. Biochim. Biophys. Acta 1106:23–30.
- J. Escoriaza, A. Aldaz, C. Castellanos, E. Calvo, and J. Giráldez. (2000). Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: Application to clinical pharmacokinetic studies. J. Chromatogr. B 740:159–168.
- J Filipovic-Grcic, N. Skalko-Basnet, and I. Jalsenjak. (2001). Mucoadhesive chitosan-coated liposomes: Characteristics and stability. J. Microencapsul. 18:3–12.
- G. Gregoriadis. (1995). Engineering liposomes for drug delivery: Progress and problems. Trend Biotechnol. 13:527–537.
- J. Guo, Q. Ping, and G. Jiang. (2003). Chitosan-coated liposomes: Characterization and interaction with leuprolide. Int. J. Pharm. 260:167–173.
- M. C. Haaz, L. P. Rivory, C. Riche, L. Vernillet, and J. Robert. (1998). Metabolism of CPT-11 by human hepatic microsomes: Participation of cytochrome P-450 3A and drug interactions. Cancer Res. 58:468–472.
- M. Jamshaid, S. J. Fair, and P. Kearney. (1988). Poloxamer adsorption on liposomes: Comparison with polystyrene latex and influence on solute efflux. Int. J. Pharm. 48:125–131.
- K. Jorg. (2001). Nanoparticulate systems for brain delivery of drugs. Drug Deliv. Res. 47:65–81.
- Y. Kawato, M. Aonuma, Y. Hirota, H. Kuga, and K. Sato. (1991). Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res. 51:4187–4191.
- D. D. Lasic. (1998). Novel applications of liposomes. TTBETECH 16:307–321.
- T. D. Madden, A. S. Janoff, and P. R. Cullis. (1990). Incorporation of amphotericin B into large unilamellar vesicles composed of phosphatidylcholine and phosphatidylglycerol. Chem. Phys. Lipids 52 (3–4):189–198.
- M. C. Nacucchio, M. J. Gatto Bellora, D. O. Sordelli, and M. D'Aquino. (1988). Enhanced liposome-mediated antibacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro. J Microencapsul. 5 (4):303–309.
- R. G. Rengel, and K. P. Barisic. (2002). High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposome. Eur. J. Pharm. Sci 15:123–129.
- L. P. Rivory, M. R. Bowles, J Robert, and S. M. Pond. (1996). Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase. Biochem. Pharmacol. 52:1103–1111.
- S. Sawada, S. Okajima, R. Aiyama, K. Nokata, T. Furuta, T. Yokokura, E. Sugino, K. Yamaguchi, and T. Miyasaka. (1991). Synthesis and antitumor activity of 20(S)-camptothecin derivatives: Carbamate-linked, water-soluble derivatives of 7-ethyl-10-hydroxy-camptothecin. Chem. Pharm. Bull. 39:1446–1454.
- N. Skalko, M. Brandl, M. Becirevic-Lacan, J. Filipovic-Grcic, and I. Jalsenjak. (1996). Liposomes with nifedipine and nifedipine-cyclodextrin complex: Calorimetrical and plasma stability comparison. Eur. J. Pharm. Sci 4:359–366.
- R. Xie, R. H. J. Mathijssen, A. Sparreboom, J. Verweij, and M. O. Karlsson. (2002). Clinical pharmacokinetics of irinotecan and its metabolites: A population analysis. J. Clin. Oncol. 20:3293–3301.
- N. Yerushalmi, and R. Margalit. (1994). Bioadhesive, collagen-modified liposomes: Molecular and cellular level studies on the kinetic of drug release and on binding to cell monolayers. BBA-Biomembranes 1189:13–20.
- N. J. Zuidam, D. Hirsch-Lerner, S. Margulies, and Y. Barenholz. (1999). Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency. Biochim. Biophys. Acta 1419:207–220.